Arqule (ARQL) Stock Price, Quote, News and Overview
NASDAQ:ARQL - Nasdaq -
ARQL Quote, Performance and Key Statistics
20
+0.03 (+0.15%)
The current stock price of ARQL is 20 null. In the past month the price decreased by -0.6%. In the past year, price increased by 434.76%.
About ARQL
Company Profile
ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer. ArQule's lead clinical-stage products have been generated from two scientific platforms: Cancer Survival Protein modulation and Activated Checkpoint Therapy. The Cancer Survival Protein modulation platform has generated a clinical-stage product that mediates its effects by inhibiting the activity of a molecule known as c-Met, which plays multiple roles in cancer cell growth, survival, invasion, angiogenesis and metastasis. The ACT platform is designed to kill cancer cells selectively while sparing normal cells through direct activation of DNA damage response/checkpoint pathways. The Company's lead ACT program, based on the E2F-1 pathway, is partnered with Roche.
Company Info
Arqule
ONE WALL STREET
BURLINGTON MA 01803
CEO: Paolo Pucci
Phone: 781-994-0300
Arqule / ARQL FAQ
What is the stock price of Arqule today?
The current stock price of ARQL is 20 null. The price increased by 0.15% in the last trading session.
What is the ticker symbol for Arqule stock?
The exchange symbol of Arqule is ARQL and it is listed on the Nasdaq exchange.
On which exchange is ARQL stock listed?
ARQL stock is listed on the Nasdaq exchange.
What is Arqule worth?
Arqule (ARQL) has a market capitalization of 2.42B null. This makes ARQL a Mid Cap stock.
What are the support and resistance levels for Arqule (ARQL) stock?
Arqule (ARQL) has a support level at 20 and a resistance level at 20.06. Check the full technical report for a detailed analysis of ARQL support and resistance levels.
Should I buy Arqule (ARQL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ARQL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ARQL, evaluating the profitability, health, valuation and growth aspects
- Arqule (ARQL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Arqule (ARQL) Sales and EPS estimates to see what analysts future expectations are.
- Arqule (ARQL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Arqule (ARQL) Insider and Institutional Ownership to learn about the owners and their transactions.
- Arqule (ARQL) Stock Chart to make your own analysis
- Arqule (ARQL) Latest news and press-releases to stay up to date.
Does Arqule (ARQL) stock pay dividends?
ARQL does not pay a dividend.
What is the Price/Earnings (PE) ratio of Arqule (ARQL)?
Arqule (ARQL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.34).
ARQL Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to ARQL. When comparing the yearly performance of all stocks, ARQL is one of the better performing stocks in the market, outperforming 99.67% of all stocks.
ARQL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ARQL. No worries on liquidiy or solvency for ARQL as it has an excellent financial health rating, but there are worries on the profitability.
ARQL Financial Highlights
Over the last trailing twelve months ARQL reported a non-GAAP Earnings per Share(EPS) of -0.34. The EPS decreased by -112.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -808.06% | ||
| ROA | -21.4% | ||
| ROE | N/A | ||
| Debt/Equity | 0.08 |
ARQL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 67% to ARQL. The Buy consensus is the average rating of analysts ratings from 6 analysts.